Skip to content

Clinical trials

Phase 2 Leiomyosarcoma trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leiomyosarcoma Phase: Phase 2 Country / region: France Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20052
20081
20111
20151
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institut Bergonié2
UNICANCER2
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
GlaxoSmithKline1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Pierre Fabre Medicament1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leiomyosarcoma9
Sarcoma6
Neoplasm Metastasis3
Sarcoma, Synovial3
Liposarcoma2
Rhabdomyosarcoma2
Epstein-Barr Virus Infections1
Fibrosarcoma1
Gastrointestinal Stromal Tumors1
Hemangiosarcoma1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.